Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SLNO | SOLENO THERAPEUTICS INC | $31.34 | $42.68 | -26.58% | 78.35x | 7.29x | 8.36x | 3.59x | 0.27x | $46.73M | 2.93% | $450.12M | 8.86 | $1.60B | 55.20 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $308.05 | $81.83 | 276.46% | 128.89x | 41.29x | 10.87x | 51.77x | 1.55x | $465.38M | 1.15% | $789.18M | 6.02 | $42.17B | 66.78 | ||
| ADMA | ADMA BIOLOGICS INC | $11.33 | $11.18 | 1.34% | 18.27x | 12.27x | 5.29x | 5.65x | 0.50x | $27.82M | 1.03% | $477.32M | 2.00 | $2.68B | 13.56 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.15 | $19.42 | -52.89% | 6.54x | 16.16x | 4.75x | 3.47x | 0.27x | -$1.99M | -0.39% | $154.66M | 2.80 | $538.01M | 5.42 | ||
| KRYS | KRYSTAL BIOTECH INC | $247.09 | $108.01 | 128.76% | 34.90x | 31.39x | 18.38x | 5.92x | 1.23x | $189.35M | 2.65% | $1.22B | 42.14 | $6.74B | 34.36 | ||
| CORT | CORCEPT THERAPEUTICS INC | $33.82 | $26.47 | 27.76% | 35.60x | 40.93x | 4.61x | 5.55x | 0.55x | $141.79M | 4.04% | $647.81M | 6.24 | $3.48B | 77.05 | ||
| ABEO | ABEONA THERAPEUTICS INC | $4.33 | $18.44 | -76.51% | 3.23x | -67.55x | 39.36x | 1.55x | 0.13x | -$84.30M | -36.77% | $159.22M | 3.01 | $193.55M | 2.46 | ||
| HALO | HALOZYME THERAPEUTICS INC | $62.04 | $69.29 | -10.46% | 23.50x | 7.59x | 5.32x | 149.99x | 0.39x | $644.59M | 8.67% | $48.81M | 0.41 | $9.33B | 16.28 | ||
| RPRX | ROYALTY PHARMA PLC | $45.57 | $41.13 | 10.80% | 25.46x | 8.82x | 8.24x | 2.71x | 0.50x | $2.22B | 11.33% | $9.71B | 22.60 | $34.62B | 32.10 | ||
| VCEL | VERICEL CORP | $33.08 | $8.25 | 300.84% | 100.24x | 64.06x | 6.03x | 4.74x | 1.77x | $24.75M | 1.49% | $354.64M | 7.05 | $1.68B | 48.00 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $4.54 | $4.30 | 5.62% | 20.64x | 15.09x | 2.78x | 4.75x | 0.51x | $13.21M | 3.68% | $76.53M | 0.97 | $301.59M | 15.35 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $27.10 | $36.32 | -25.38% | 9.82x | 7.48x | 1.79x | 1.80x | 0.44x | $347.89M | 22.33% | $870.22M | 15.14 | $978.64M | 3.84 | ||
| TECH | BIO-TECHNE CORP | $52.43 | $15.38 | 240.85% | 100.83x | 25.86x | 6.72x | 4.08x | 1.45x | $223.02M | 2.73% | $2.01B | 12.90 | $8.38B | 37.01 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $54.09 | $45.58 | 18.68% | 29.72x | 11.56x | 3.22x | 1.71x | 0.53x | $724.96M | 6.99% | $6.09B | 31.74 | $9.69B | 16.91 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $17.23 | $4.94 | 248.73% | 95.72x | -14.51x | 2.17x | 5.95x | 1.51x | $45.01M | 2.07% | $370.15M | 2.93 | $2.21B | 31.56 | ||
| MNKD | MANNKIND CORP | $2.29 | $1.08 | 111.82% | 114.50x | 42.96x | 2.01x | -13.83x | 0.82x | $13.69M | 1.97% | -$51.02M | -0.17 | $1.24B | 23.34 | ||
| EXEL | EXELIXIS INC | $41.57 | $34.23 | 21.44% | 14.43x | 13.25x | 4.87x | 5.00x | 0.77x | $875.84M | 7.76% | $2.16B | 7.96 | $10.49B | 10.54 | ||
| XOMA | XOMA ROYALTY CORP | $29.22 | $14.34 | 103.70% | 19.10x | 92.94x | 6.77x | 4.14x | 1.68x | -$1.83M | -0.52% | $83.94M | 6.95 | $391.09M | 11.28 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.07 | $13.73 | 68.08% | 13.18x | 11.94x | 4.79x | 2.95x | 1.89x | $208.61M | 7.39% | $954.27M | 7.80 | $2.11B | 6.56 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $741.69 | $428.35 | 73.15% | 17.22x | 15.86x | 5.41x | 2.51x | 1.32x | $4.08B | 5.26% | $31.26B | 298.82 | $78.00B | 13.41 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $201.66 | $76.30 | 164.31% | 31.31x | 23.75x | 14.55x | 3.95x | 1.69x | $48.09M | 1.23% | $1.02B | 52.60 | $4.30B | 21.55 | ||
| VCYT | VERACYTE INC | $32.94 | $11.81 | 178.84% | 39.21x | 28.48x | 5.01x | 2.00x | 1.57x | $126.63M | 4.89% | $1.31B | 16.67 | $2.29B | 24.76 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $448.62 | $173.98 | 157.86% | 29.02x | 23.14x | 9.56x | 6.11x | 1.73x | $3.19B | 2.78% | $18.67B | 73.00 | $110.73B | 22.75 | ||
| UTHR | UNITED THERAPEUTICS CORP | $531.82 | $236.48 | 124.89% | 17.65x | 17.81x | 7.40x | 3.28x | 2.53x | $1.04B | 4.42% | $7.10B | 160.19 | $21.75B | 11.96 | ||
| INCY | INCYTE CORP | $90.62 | $67.55 | 34.15% | 13.75x | 11.83x | 3.44x | 3.49x | 0.99x | $1.35B | 7.66% | $5.17B | 26.47 | $14.97B | 8.50 | ||
| MDXG | MIMEDX GROUP INC | $4.13 | $1.86 | 121.71% | 12.52x | 35.73x | 1.46x | 2.39x | 20.39x | $72.97M | 11.96% | $256.55M | 1.74 | $465.43M | 5.86 | ||
| CRMD | CORMEDIX INC | $6.46 | $12.35 | -47.69% | 2.87x | 4.75x | 1.49x | 1.26x | 17.46x | $172.79M | 37.14% | $405.31M | 5.63 | $514.74M | 3.08 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.